#United States #New York #healthcare #Novavax #Jefferies

Novavax to Participate in the 2026 Jefferies Global Healthcare Conference

Novavax, Inc. (Nasdaq: NVAX), a company recognized for its innovative solutions in the healthcare landscape, has recently announced its participation in the highly anticipated 2026 Jefferies Global Healthcare Conference. This annual event serves as a crucial platform for healthcare professionals and industry leaders to explore the latest advancements and insights in the field.

Conference Details

The event is scheduled for Thursday, June 4, 2026, and will feature a fireside chat from 10:30 to 11:00 AM Eastern Time. The venue will be New York City, where Novavax aims to engage with investors and other stakeholders about their cutting-edge research and development endeavors.

For those unable to attend in person, the company will host a webcast of the fireside chat, which will be accessible on the company's Events & Presentations page at ir.novavax.com. A recorded replay will also be available for 30 days post-event, ensuring that all interested parties can catch up on the discussions at their convenience.

About Novavax

At the core of Novavax’s mission is the commitment to address some of the most pressing health challenges facing the global community. Utilizing a robust technological platform, the company excels in vaccine development, leveraging innovative strategies such as the Matrix-M® adjuvant and protein-based nanoparticles to enhance immune responses.

The company’s strategic approach includes three primary pillars: partnerships to maximize technology utilization, efficient research and development innovations, and a streamlined operational model. These strategies collectively aim to strengthen the impact of their marketed products, including Nuvaxovid and the R21/Matrix-M™ vaccine, while also advancing their other research and development assets.

By participating in vital conferences such as the Jefferies Global Healthcare Conference, Novavax is poised to strengthen its network within the healthcare ecosystem, showcasing its advancements and engaging in critical discussions that could shape future healthcare policies and practices.

For further details about their initiatives and updates, the public can follow Novavax on their official website and LinkedIn page. As healthcare continues to evolve, Novavax remains at the forefront, dedicated to improving global health through innovation and collaboration.

Contact Information for Investors

For those interested in investor relations, please reach out to:

• - Jim Kelly

Phone: 844-668-2829
Email: [email protected]

Media Inquiries

For media-related questions, contact:

• - Yvonne Sprow

Phone: 844-264-8571
Email: [email protected]

Conclusion

The upcoming conference presents an exciting opportunity for Novavax to share its vision and showcase advancements in the healthcare field. As the date approaches, stakeholders and interested public members are encouraged to engage with Novavax to better understand the company’s direction and contributions to health innovation.